154 related articles for article (PubMed ID: 31109700)
1. Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients.
Sapienza LG; Ning MS; Taguchi S; Calsavara VF; Pellizzon ACA; Gomes MJL; Kowalski LP; Baiocchi G
Oral Oncol; 2019 Jun; 93():8-14. PubMed ID: 31109700
[TBL] [Abstract][Full Text] [Related]
2. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
Warner L; Lee K; Homer JJ
Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
[TBL] [Abstract][Full Text] [Related]
5. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.
Chone CT; Yonehara E; Martins JE; Altemani A; Crespo AN
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):882-7. PubMed ID: 17875854
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.
Kitani Y; Kubota A; Furukawa M; Sato K
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1011-7. PubMed ID: 25726168
[TBL] [Abstract][Full Text] [Related]
7. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
10. Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States.
Stokes WA; Stumpf PK; Jones BL; Blatchford PJ; Karam SD; Lanning RM; Raben D
Oral Oncol; 2017 Sep; 72():110-116. PubMed ID: 28797446
[TBL] [Abstract][Full Text] [Related]
11. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
12. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
13. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
[TBL] [Abstract][Full Text] [Related]
15. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of anterior commissure involvement in T1 glottic cancer: A systematic review and meta-analysis.
Tulli M; Re M; Bondi S; Ferrante L; Dajko M; Giordano L; Gioacchini FM; Galli A; Bussi M
Laryngoscope; 2020 Aug; 130(8):1932-1940. PubMed ID: 31721216
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
19. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.
Warde P; O'Sullivan B; Bristow RG; Panzarella T; Keane TJ; Gullane PJ; Witterick IP; Payne D; Liu FF; McLean M; Waldron J; Cummings BJ
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):347-53. PubMed ID: 9607350
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
